The 2024 Diagnosis Related Groups dataset
DRG 816
Reticuloendothelial and immunity disorders without cc/mcc
A18.2 Tuberculous peripheral lymphadenopathy
A18.85 Tuberculosis of spleen
A28.1 Cat-scratch disease
D15.0 Benign neoplasm of thymus
D18.1 Lymphangioma, any site
D36.0 Benign neoplasm of lymph nodes
D3A.091 Benign carcinoid tumor of the thymus
D47.2 Monoclonal gammopathy
D47.3 Essential (hemorrhagic) thrombocythemia
D47.4 Osteomyelofibrosis
D68.312 Antiphospholipid antibody with hemorrhagic disorder
D68.51 Activated protein C resistance
D68.52 Prothrombin gene mutation
D68.59 Other primary thrombophilia
D68.61 Antiphospholipid syndrome
D68.62 Lupus anticoagulant syndrome
D68.69 Other thrombophilia
D72.10 Eosinophilia, unspecified
D72.110 Idiopathic hypereosinophilic syndrome [IHES]
D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
D72.118 Other hypereosinophilic syndrome
D72.119 Hypereosinophilic syndrome [HES], unspecified
D72.12 Drug rash with eosinophilia and systemic symptoms syndrome
D72.18 Eosinophilia in diseases classified elsewhere
D72.19 Other eosinophilia
D72.810 Lymphocytopenia
D72.818 Other decreased white blood cell count
D72.819 Decreased white blood cell count, unspecified
D72.820 Lymphocytosis (symptomatic)
D72.821 Monocytosis (symptomatic)
D72.822 Plasmacytosis
D72.823 Leukemoid reaction
D72.824 Basophilia
D72.825 Bandemia
D72.828 Other elevated white blood cell count
D72.829 Elevated white blood cell count, unspecified
D72.89 Other specified disorders of white blood cells
D72.9 Disorder of white blood cells, unspecified
D73.0 Hyposplenism
D73.1 Hypersplenism
D73.2 Chronic congestive splenomegaly
D73.3 Abscess of spleen
D73.4 Cyst of spleen
D73.5 Infarction of spleen
D73.81 Neutropenic splenomegaly
D73.89 Other diseases of spleen
D73.9 Disease of spleen, unspecified
D75.0 Familial erythrocytosis
D75.1 Secondary polycythemia
D75.838 Other thrombocytosis
D75.839 Thrombocytosis, unspecified
D75.89 Other specified diseases of blood and blood-forming organs
D75.9 Disease of blood and blood-forming organs, unspecified
D75.A Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia
D76.1 Hemophagocytic lymphohistiocytosis
D76.2 Hemophagocytic syndrome, infection-associated
D76.3 Other histiocytosis syndromes
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
D80.0 Hereditary hypogammaglobulinemia
D80.1 Nonfamilial hypogammaglobulinemia
D80.2 Selective deficiency of immunoglobulin A [IgA]
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
D80.4 Selective deficiency of immunoglobulin M [IgM]
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
D80.7 Transient hypogammaglobulinemia of infancy
D82.2 Immunodeficiency with short-limbed stature
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
D82.4 Hyperimmunoglobulin E [IgE] syndrome
D82.8 Immunodeficiency associated with other specified major defects
D82.9 Immunodeficiency associated with major defect, unspecified
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
D83.8 Other common variable immunodeficiencies
D83.9 Common variable immunodeficiency, unspecified
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
D84.81 Immunodeficiency due to conditions classified elsewhere
D84.821 Immunodeficiency due to drugs
D84.822 Immunodeficiency due to external causes
D84.89 Other immunodeficiencies
D84.9 Immunodeficiency, unspecified
D89.0 Polyclonal hypergammaglobulinemia
D89.2 Hypergammaglobulinemia, unspecified
D89.3 Immune reconstitution syndrome
D89.40 Mast cell activation, unspecified
D89.41 Monoclonal mast cell activation syndrome
D89.42 Idiopathic mast cell activation syndrome
D89.43 Secondary mast cell activation
D89.44 Hereditary alpha tryptasemia
D89.49 Other mast cell activation disorder
D89.831 Cytokine release syndrome, grade 1
D89.832 Cytokine release syndrome, grade 2
D89.833 Cytokine release syndrome, grade 3
D89.834 Cytokine release syndrome, grade 4
D89.835 Cytokine release syndrome, grade 5
D89.839 Cytokine release syndrome, grade unspecified
D89.84 IgG4-related disease
D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified
D89.9 Disorder involving the immune mechanism, unspecified
E32.0 Persistent hyperplasia of thymus
E32.1 Abscess of thymus
E32.8 Other diseases of thymus
E32.9 Disease of thymus, unspecified
I88.1 Chronic lymphadenitis, except mesenteric
I88.8 Other nonspecific lymphadenitis
I88.9 Nonspecific lymphadenitis, unspecified
I89.8 Other specified noninfective disorders of lymphatic vessels and lymph nodes
I89.9 Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
L04.0 Acute lymphadenitis of face, head and neck
L04.1 Acute lymphadenitis of trunk
L04.2 Acute lymphadenitis of upper limb
L04.3 Acute lymphadenitis of lower limb
L04.8 Acute lymphadenitis of other sites
L04.9 Acute lymphadenitis, unspecified
Q89.01 Asplenia (congenital)
Q89.09 Congenital malformations of spleen
R16.1 Splenomegaly, not elsewhere classified
R59.0 Localized enlarged lymph nodes
R59.1 Generalized enlarged lymph nodes
R59.9 Enlarged lymph nodes, unspecified
R75 Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
R76.0 Raised antibody titer
R76.8 Other specified abnormal immunological findings in serum
R76.9 Abnormal immunological finding in serum, unspecified
S36.00XA Unspecified injury of spleen, initial encounter
S36.020A Minor contusion of spleen, initial encounter
S36.021A Major contusion of spleen, initial encounter
S36.029A Unspecified contusion of spleen, initial encounter
S36.030A Superficial (capsular) laceration of spleen, initial encounter
S36.031A Moderate laceration of spleen, initial encounter
S36.032A Major laceration of spleen, initial encounter
S36.039A Unspecified laceration of spleen, initial encounter
S36.09XA Other injury of spleen, initial encounter
T80.82XA Complication of immune effector cellular therapy, initial encounter
Z94.81 Bone marrow transplant status
Z94.84 Stem cells transplant status